The impact of "4 + 7" volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
Abstract Background In 2019, Chinese government launched a nationwide volume-based drug procurement aiming at reducing drug prices and saving drug costs through economies of scale, which aroused widespread attention. The first round of the policy pilot was implemented in 4 municipalities and 7 sub-p...
Saved in:
Main Authors: | Ying Yang (Author), Ruiwen Tong (Author), Shicheng Yin (Author), Lining Mao (Author), Luxinyi Xu (Author), Siyu Hao (Author), Zongfu Mao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis
by: Ying Yang, et al.
Published: (2021) -
Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
by: Ni Wang, et al.
Published: (2021) -
The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City: An Interrupted Time Series Analysis
by: Xiaotong Wen, et al.
Published: (2021) -
Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin
by: Boya Zhao, et al.
Published: (2023) -
The impact of Chinese volume-based procurement on pharmaceutical market concentration
by: Ying Yang, et al.
Published: (2024)